ClinicalTrials.gg
RecruitingNCT07227974Updated Oct 21, 2026

Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays

An interventional study of Therapist-Delivered Early Intervention Approach and Caregiver Coaching Early Intervention Approach in Developmental Delays, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 12 Months to 32 Months. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Updated Oct 21, 2026Eligibility revisedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
1,269
Allocation
Randomized
Ages
12 Months to 32 Months
Sex
All
01

Study summary

This study is testing three ways to deliver Early Intervention (EI) services for toddlers with developmental disabilities (DD).

Children enrolled in EI speech therapy will receive one of three approaches:

  1. Therapist Delivered EI: For 28 weeks, the child's speech therapist will work directly with the child to support their communication.
  2. Caregiver Coaching EI: For 28 weeks, the child's speech therapist will coach the caregiver on how to support their child's communication.
  3. Combined EI Approach + Parent-Led Education Program: For 14 weeks, the caregiver will take part in a parent-led education program while the speech therapist works directly with the child to support their communication. During the next 14 weeks, the speech therapist will coach the caregiver on how to support their child's communication.

The goal of this study is to identify which approaches are most effective so that all families can benefit fully from EI services.

Read the detailed description

High-quality Early Intervention (EI) during the first three years of life, a period of heightened neuroplasticity, is critical to improving outcomes for children with developmental disabilities (DD). There are two EI approaches that may be effective for supporting child communication and improving family outcomes: 1) caregiver coaching, in which the EI therapist teaches the caregiver strategies to help their child's communication, and 2) caregiver psychoeducation, in which a peer mentor teaches the caregiver about skills and resources that are helpful in supporting their child and family.

The aim of the current clinical trial is to determine which EI approaches are most effective, for which families, and why they are effective. This clinical trial also aims to investigate how therapists are delivering the interventions and to characterize the acceptability and feasibility of these interventions for use in real-world settings.

A total of 1,269 toddlers (approximately equal numbers of Black, Latine, and white children) will be enrolled across community-based EI sites. Families will be directly recruited from participating EI therapists' existing caseloads. Caregiver-child dyads will be randomly assigned to one of three groups:

  1. Therapist Delivered EI: For 28 weeks, the child's speech therapist will work directly with the child to support their communication.
  2. Caregiver Coaching EI: For 28 weeks, the child's speech therapist will coach the caregiver on how to support their child's communication.
  3. Combined EI Approach + Parents Taking Action: For 14 weeks, the caregiver will take part in a parent-led education program (Parents Taking Action) while the speech therapist works directly with the child to support their communication. During the next 14 weeks, the speech therapist will coach the caregiver on how to support their child's communication.

Outcomes will assess both caregiver and child domains, including caregiver use of responsive strategies, caregiver capacity to support the child's needs, and child social communication. The study will also examine moderators (e.g., race) and mediators (e.g., caregiver use of responsive strategies) to identify for whom and why each approach is most effective.

A process evaluation will assess implementation fidelity (quality, dosage, adaptations) and explore how fidelity influences effectiveness outcomes. Feasibility, acceptability, and appropriateness of each approach will be evaluated through surveys and interviews with caregivers and EI therapists.

This study is among the first large-scale comparative effectiveness trials of early intervention approaches conducted in real-world EI settings. Findings will inform EI practices and guide caregivers, therapists, and policymakers in selecting interventions that best meet the needs and preferences of diverse families.

02

Conditions studied

  • Developmental Delays

Keywords

  • Developmental Disabilities
  • Language Delay
  • Caregiver Coaching
  • Caregiver Responsiveness
  • Early Intervention
  • Pragmatic Clinical Trial
  • Communication
  • Speech-Language Pathology
  • Patient-Centered Outcomes Research
03

In context

Developmental Disabilities

230 studies on the registry are indexed under Developmental Disabilities; 65 are open to participants now.

This study's planned enrollment of 1,269 is above the median of 60 across 150 interventional studies indexed under Developmental Disabilities.

Browse Developmental Disabilities studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,423 studies on the registry; 198 are open to participants now.

Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 21, 2026. See what changed

Ages eligible
12 Months to 32 Months
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Child Inclusion Criteria:

  • At least 12 months old
  • Functional communication skills at an age equivalent of at least 6 months
  • At least 7 months of Early Intervention (EI) service eligibility remaining
  • Enrolled in the Illinois EI system and is new to the speech-language pathologist's (SLP's) caseload (i.e., no prior EI speech-language therapy experience with the SLP)
  • Plans to receive one hour of speech-language therapy per week in the home or in a private space outside of the home

Child Exclusion Criteria:

- Exposed to a language other than English or Spanish more than 10% of the time

Caregiver Inclusion Criteria:

  • The child's parent, legal guardian, or other family member
  • Self-identifies as Black, Latine (Hispanic), or white
  • Available to participate in weekly EI sessions and study assessments

Caregiver Exclusion Criteria

  • Younger than 18 years old at enrollment
  • Uses a language other than English or Spanish during their interactions with the child more than 10% of the time
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
1,269 participants (estimated)

Study arms

  • Active comparator
    Therapist-Delivered Early Intervention Approach

    For 28 weeks, this arm will receive the therapist-delivered early intervention approach.

    Behavioral: Therapist-Delivered Early Intervention Approach

  • Experimental
    Caregiver Coaching Early Intervention Approach

    For 28 weeks, this arm will receive the caregiver coaching early intervention approach.

    Behavioral: Caregiver Coaching Early Intervention Approach

  • Experimental
    Combined Early Intervention Approach + Parents Taking Action

    For the first 14 weeks, this arm will receive the therapist-delivered early intervention as well as Parents Taking Action. For the following 14 weeks, this arm will receive the caregiver coaching early intervention approach.

    Behavioral: Therapist-Delivered Early Intervention Approach · Behavioral: Caregiver Coaching Early Intervention Approach · Behavioral: Parents Taking Action

Interventions

  • BehavioralTherapist-Delivered Early Intervention Approach

    The therapist-delivered early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions. During the sessions, the child's EI speech-language pathologist (SLP) will use responsive strategies directly with the child. Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention. The SLP will not coach the caregiver during the sessions.

  • BehavioralCaregiver Coaching Early Intervention Approach

    The caregiver-coaching early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions. During the sessions, the child's EI speech-language pathologist (SLP) will coach the caregiver to use responsive strategies with their child. Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention.

  • BehavioralParents Taking Action

    Parents Taking Action (PTA) will be delivered during weekly, one-hour virtual sessions with the caregiver, separate from the child's early intervention (EI) sessions. PTA is a psychoeducation program implemented by a peer mentor (i.e., a culturally-matched caregiver of a child with a developmental disability). During the sessions, the peer mentor will provide information and guidance on a range of topics (e.g., child development, early intervention systems, special education rights/resources, and advocacy) following a structured curriculum.

06

What researchers measure

Primary outcomes

  1. Responsive Strategy Use (RSU) Rating Scale

    The Responsive Strategy Use (RSU) Rating Scale will be used to measure caregivers' use of responsive strategies during a naturalistic, caregiver-child interaction. Items on the RSU Rating Scale are rated on a 4-point Likert Scale (0 = Rarely/Never, 3 = Consistently) and averaged to yield the RSU Total Score (Min = 0, Max = 3), with higher scores reflecting a higher frequency of responsive strategy use.

    Time frame: Week 14, Week 28

  2. Family Outcomes Survey - Revised

    The Family Outcomes Survey-Revised is a 24-item informant-report questionnaire that assesses caregivers' understanding, confidence, and ability to support their child's needs. The Family Outcomes Total Score (Min = 24, Max = 120) reflects the caregiver's capacity to support their child's needs, with higher scores indicating greater capacity.

    Time frame: Week 14, Week 28

  3. Communication and Symbolic Behavior Scales - Developmental Profile (CSBS-DP)

    The Communication and Symbolic Behavior Scales - Developmental Profile (CSBS-DP) is a structured, norm-referenced, observational measure of child communication. The assessment is scored for 20 items across 7 domains (i.e., Emotion and Eye Gaze, Communication, Gestures, Sounds, Words, Understanding, Object Use). The weighted raw scores for each of the 7 domains are grouped into 3 clusters (social, speech, and symbolic) and combined into a total raw score (min = 0; max = 113). Higher scores indicate better skills.

    Time frame: Week 28

Secondary outcomes

  1. Session Attendance

    Session attendance will be documented in weekly session logs completed by interventionists and summarized as the percentage of planned intervention sessions attended by each family (Min = 0%, Max = 100%).

    Time frame: Week 1 to Week 28

  2. Intervention Fidelity Checklist

    The Intervention Fidelity Checklist is a rating scale assessing adherence to the intervention protocol. Items on the checklist correspond to the core elements of the respective intervention protocol and are scored based on specific behavioral criteria. The Intervention Fidelity Checklist will be scored on a randomly selected 20% of intervention sessions per participant. Scores will be averaged across sessions to yield an average intervention quality score (Min = 0, Max = 100), with higher scores indicating higher intervention quality.

    Time frame: Week 1 to Week 28

  3. Framework for Reporting Adaptations and Modifications (FRAME)

    The Framework for Reporting Adaptations and Modifications (FRAME) will be used to document intervention adaptations. Adaptations will be documented through intervention session logs and direct observations of intervention sessions. These data will yield the total number of adaptations (Min = 0, Max = NA).

    Time frame: Week 1 to Week 28

Other outcomes

  1. Early Intervention Program Satisfaction Scale

    An adapted version of the Early Intervention Program Satisfaction Scale, a caregiver-report questionnaire, will be used to assess caregiver satisfaction. This survey includes 6 items rated on a 5-point Likert (1 = Very Dissatisfied, 5 = Very Satisfied). The Total Score (Min = 6, Max = 30) reflects caregivers' overall satisfaction with the intervention, with higher scores representing greater satisfaction.

    Time frame: Week 14, Week 28

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) that underlie the results reported in any publication arising from this trial will be made publicly available via the Dryad repository. The shared dataset will include all variables necessary to reproduce the published findings, including treatment assignment, participant demographics, baseline characteristics, and outcome measures. All data will be de-identified in accordance with HIPAA standards and institutional policies to protect participant confidentiality. Data will be uploaded to Dryad after publication of the primary results, and will be freely accessible to qualified researchers without restriction. A corresponding DOI will be provided in publications to facilitate data access and citation.

Supporting information: Analytic code

Time frame: Data will be uploaded to the Dryad data repository on November 1st, 2030 and remain there indefinitely.

Access criteria: De-identified individual participant data (IPD) and supporting documentation (e.g., data dictionaries, survey instruments, codebooks) will be publicly available to any researcher or member of the public. All data will be uploaded to the Dryad Digital Repository, where users can freely access and download the datasets. No special request or application will be required to access the IPD. The data will be shared in a de-identified format to protect participant privacy, and users will be able to access the IPD along with associated documentation necessary to understand and use the data for secondary analyses or replication studies.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Mar 2030, 49 months after the start.

Of 96 non-industry interventional studies with no phase under Developmental Disabilities, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 49. This study's planned 49 months is above that.

Counting every sponsor, half of 97 studies reached it within 22 months; a quarter within 13 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2025
First posted
Nov 13, 2025
StartActual
Feb 16, 2026
Primary completionEst.
Mar 2030
CompletionEst.
Jun 2030
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
Maximum age 31 Months→32 Months; 1 criterion added
What changed in the criteria
  • AddedFunctional communication skills at an age equivalent of at least 6 months
across 2 updates, Oct 2, 2026 – Oct 21, 2026
Show all 2 updates
  1. Oct 21, 2026
    Eligibility 1 criterion added
    What changed in the criteria
    • AddedFunctional communication skills at an age equivalent of at least 6 months
    + 1 other change: verification date
  2. Oct 2, 2026
    Eligibility Maximum age 31 Months→32 Months
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07227974
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Megan Roberts (Principal Investigator, Northwestern University) — Principal investigator
First posted
Nov 13, 2025
Start date
Feb 16, 2026
Primary completion
Mar 2030 (estimated)
Completion
Jun 2030 (estimated)
Last update
Oct 21, 2026

Study contacts

Laura Sudec, Masters
Contact
laura.sudec@northwestern.edu
1-847-491-3183
Megan Roberts, PhD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion